Bolivia vs Trinidad and Tobago: Treatment success rate for patients treated for MDR-TB
Bolivia
42.0%
in 2022
Trinidad and Tobago
33.0%
in 2020
Bolivia rank
149th
Trinidad and Tobago rank
151st
Treatment success rate for patients treated for MDR-TB over time
- Bolivia
- Trinidad and Tobago
How they compare
Bolivia currently reports 42.0% against 33.0% in Trinidad and Tobago, a difference of 9.0%.
That makes Bolivia's figure about 1.3 times Trinidad and Tobago's.
The two have swapped places 1 time across 6 shared years of data; in 2013 it was Trinidad and Tobago ahead.
Bolivia ranks 149th and Trinidad and Tobago ranks 151st of 163 countries.
Bolivia has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Bolivia | Trinidad and Tobago | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 65.4% | 24.2% | 41.2% | Bolivia |
| 2020s | 58.0% | 33.0% | 25.0% | Bolivia |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher treatment success rate for patients treated for mdr-tb, Bolivia or Trinidad and Tobago?
- Bolivia, at 42.0% against 33.0% in Trinidad and Tobago as of 2022.
- What is the difference in treatment success rate for patients treated for mdr-tb between Bolivia and Trinidad and Tobago?
- 9.0%, with Bolivia ahead.
- How many years of comparable data are there for Bolivia and Trinidad and Tobago?
- 6 years are reported by both, from 2013 to 2020.
- How do Bolivia and Trinidad and Tobago rank globally for treatment success rate for patients treated for mdr-tb?
- Bolivia ranks 149th and Trinidad and Tobago ranks 151st of 163 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Treatment success rate for patients treated for MDR-TB (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.